Dagens hearing? (Uppdatering)

Om någon har länk till Kersti och SAS-snubbens hearing idag får man gärna mejla över den. 
Är bra nyfiken på hur samstämda dessa 2 var. 😎 Mvh the99

Tillägg 26/4

Jag blev bönhörd och fick länken till sändningen så här kommer den.

RMMS Smart Manufacturing Video 2024 04 25

 

Joshua Hunsberger :

Our first speaker was Dr. Kersti Alm. She is a pioneer of non-invasive live cell imaging where she has been the CSO at an innovative company called Phase Holographic Imaging. This company is taking digital holographic imaging to the next level where it will be able to non-invasively characterize cells and develop rich data profiles that can be taken at different timepoints across an entire manufacturing production process. They are essentially paving the way for industrialized regenerative medicine. This rich characterization profile can be used in smart manufacturing processes to help regenerative medicine companies optimize their manufacturing processes, as well as, provide data profiles that can be used to help ensure safety and efficacy. Today she covered some of the current uses and future outlooks of this technology.

Our second speaker is Dr. Mark Wolff. He has 30 years of experience in the health and life science industries as a scientist and analyst working in the U.S. and Europe. He is an Advisory Industry Consultant for SAS Institute’s Global IoT Division. His work focuses on the application of machine learning and artificial intelligence approaches to streaming sensor telemetry and unstructured data in support of improving health outcomes, patient safety, and the design of intelligent, decision support systems for clinical research, care delivery and the development of next generation manufacturing quality analytics for the biopharmaceutical, regenerative medicine, and medical device industries. Today he shared some perspectives on smart manufacturing and applying this to regenerative medicine.

Key Take Aways:
- Quantitative phase imaging is a non-invasive technique for characterizing live cells that can generate rich data profiles over time to help optimize manufacturing processes and ensure safety and efficacy.
- Applying principles of smart manufacturing like automation, quality control, compliance, optimization and interoperability can help scale up regenerative medicine therapies to make them safe, accessible and affordable for more patients.
- Companies can start applying smart manufacturing by focusing on data quality and connectivity to remove humans from data handling processes and better integrate instrumentation and data systems.
- Researchers are working to identify key quality attributes and cellular measurements that can predict clinical outcomes to help optimize manufacturing processes.

Min kommentar

För de phi,are som inte riktigt haft kläm på processerna inom Reg Med produktion rekommenderar jag starkt att se utsändningen,och framförallt spetsa öronen.Kerstis tal är en kort och bra summering.Sen kommer en förkyld Dr Mark Wolff från SAS in och berättar om hur viktigt det är att kunna ta tillvara all data som finns via den digitala tekniken (tänk HoloMonitor). Samstämmigheten mellan Kersti och Mark? Jodå,de är bra tajta i resonemanget = 100% samstämda. Marks tal och efterföljande kommentarer vibbar starkt hur mycket SAS tror på att kunna använda Big Data och AI för att verkligen utnyttja all information den digitala tekniken ger.

För att sammanfatta: Joshua + Kersti + Mark ger ett enhetligt intryck över hur konfidenta de är över,i detta fall,vad PHI och SAS brings to the table (ReMDO). Good Talk !

Kommentera gärna vad ni tycker om hearingen.

                                                Mvh the99